Camlin Fine Sciences

• Vinpai posted H1 2026 revenue of EUR 3.83 million, down 22% from EUR 4.9 million a year earlier.
• Q2 revenue fell 13% to EUR 2.25 million from EUR 2.58 million.
• Sales hit by a temporary halt in exports to Algeria, following central bank controls on foreign-exchange transactions.
• Order book stood above EUR 2.7 million at June 30, down from EUR 4.1 million a year earlier.
• Management flagged a “significant” sales rebound in H2, citing new customer validations in food and cosmetics.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein.

• Camlin Fine Sciences bought 501,842 Vinpai shares at EUR 3.6 each during June 23 to July 6.
• Stake rose to 4,351,894 shares, equal to 95.41% of capital and 91.46% of theoretical voting rights.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief on July 09, 2026, and is solely responsible for the information contained therein.

• Camlin Fine Sciences ended its cash tender offer on July 6, 2026, lifting its Vinpai stake to 95.41% of share capital.
• Holding totals 4,351,894 shares, representing 91.46% of theoretical voting rights.
• Camlin Fine Sciences will not seek a squeeze-out or delisting from Euronext Growth Paris.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260708862270) on July 08, 2026, and is solely responsible for the information contained therein.

• Camlin Fine Sciences bought 18,826 Vinpai shares on July 6 at EUR 3.6 per share during a public offer period.
• Holding rose to 4,351,894 shares, with 4,325,158 voting rights.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief on July 07, 2026, and is solely responsible for the information contained therein.

• Camlin Fine Sciences disclosed it crossed 90% of Vinpai’s share capital on June 23, 2026 through a tender offer.
• It reported holding 4,163,512 shares, equal to 91.28% of capital and 87.48% of voting rights at that date.
• As of July 3, 2026, Camlin Fine Sciences reported 4,333,068 shares, equal to 94.99% of capital and 91.06% of voting rights.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief on July 06, 2026, and is solely responsible for the information contained therein.

• Camlin Fine Sciences bought 4,808 Vinpai shares on June 30 to July 2 at EUR 3.6 each during a public offer period.
• Holding rose to 4,259,919 shares following the purchases.
• Voting rights increased to 4,233,183.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief on July 03, 2026, and is solely responsible for the information contained therein.

• Camlin Fine Sciences bought 23,429 Vinpai shares on June 29 at EUR 3.6 each during a public offer period.
• Holding rose to 4,255,111 shares, representing 4,228,375 voting rights following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief on June 30, 2026, and is solely responsible for the information contained therein.

• Camlin Fine Sciences bought 9,465 Vinpai shares on June 26 at EUR 3.6 each.
• Holding rose to 4,231,682 shares following the purchase.
• Voting rights totaled 4,204,946 after the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief on June 29, 2026, and is solely responsible for the information contained therein.

• Camlin Fine Sciences bought 35,303 Vinpai shares on June 25 at EUR 3.6 per share during the ongoing tender offer.
• Holding rose to 4,222,217 shares, representing 4,195,481 voting rights.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief on June 26, 2026, and is solely responsible for the information contained therein.

• Camlin Fine Sciences bought Vinpai shares in market purchases on June 23-24 at EUR 3.6 per share.
• Deal size totaled 336,862 shares, lifting its holding to 4,186,914 shares.
• Voting rights rose to 4,160,178 following the purchases.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief on June 25, 2026, and is solely responsible for the information contained therein.

• Vinpai shareholder Nicolas Santini sold 165,254 shares on June 23 at EUR 3.6, an AMF filing showed.
• Santini held 15,192 shares and voting rights after the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief on June 23, 2026, and is solely responsible for the information contained therein.

• Camlin Fine Sciences launched a cash tender offer for Vinpai shares on Euronext Growth Paris.
• The offer is scheduled to run from June 23, 2026 through July 6, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief on June 19, 2026, and is solely responsible for the information contained therein.

• Camlin Fine Sciences filed a cash offer to buy remaining Vinpai shares it does not already own at EUR 3.6 per share.
• Offer covers 711,363 shares, representing 15.6% of share capital, excluding 26,736 treasury shares.
• Camlin Fine Sciences held 3,850,052 shares, or 84.4% of share capital, as of filing date, following a control block acquisition completed Nov. 27, 2025 and conversion of Obligations Convertibles into 1,100,000 new shares on Dec. 31, 2025.
• If all shares are tendered, total cash consideration would be about EUR 2.56 million.
• Indicative timetable shows offer opening June 23, 2026, closing July 7, 2026, with settlement on July 9, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief on May 04, 2026, and is solely responsible for the information contained therein.

Camlin Fine Sciences postponed the filing of its cash tender offer for the remaining Vinpai shares, keeping the offer price at EUR 3.6 per share. The filing is now expected by early May 2026 so Vinpai’s 2025 annual financial statements can be included in the offer documentation. Camlin Fine Sciences said it no longer plans to pursue a squeeze-out and intends to keep Vinpai listed. Camlin Fine Sciences holds 83.82% of Vinpai’s share capital and 80.86% of voting rights following its earlier acquisition and bond conversion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260316276246) on March 16, 2026, and is solely responsible for the information contained therein.